LifeStance Health Group Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, LifeStance Health Group stock has a consensus rating of "Buy" and an average price target of $13.8. The average 1-year stock price forecast is 7.56% higher than the current stock price, while the lowest is $12 (-6.47%) and the highest is $18 (+40.30%).

Price Target: $13.8 (+7.56%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$12	$13.8	$13	$18
Change	-6.47%	+7.56%	+1.33%	+40.30%

Analyst Ratings

The average analyst rating for LifeStance Health Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	7	7	7	7	7	7
Buy	2	2	2	2	2	2
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Daniels William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Aug 21, 2026
David Larsen BTIG	BTIG	Buy Maintains $16 → $18	Buy	Maintains	$16 → $18	+40.30%	Aug 19, 2026
Lisa Gill J.P. Morgan	J.P. Morgan	Hold Maintains $9 → $13	Hold	Maintains	$9 → $13	+1.33%	Aug 14, 2026
Craig Hettenbach Morgan Stanley	Morgan Stanley	Buy Reiterates $13	Buy	Reiterates	$13	+1.33%	Aug 12, 2026
Peter Warendorf Barclays	Barclays	Buy Reiterates $13	Buy	Reiterates	$13	+1.33%	Aug 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.71B

from 1.42B

19.92%

from 1.42B

Revenue Next Year

1.95B

from 1.71B

14.40%

from 1.71B

EPS This Year

0.40

from 0.18

116.84%

from 0.18

EPS Next Year

0.53

from 0.40

34.19%

from 0.40

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	667.51M	859.54M	1.06B	1.25B	1.42B	1.71B
Revenue Growth	76.96%	28.77%	22.82%	18.50%	13.85%	19.92%
Gross Profit	201.51M	237.02M	302.10M	402.40M	461.10M	580.60M
Gross Margin	30.19%	27.57%	28.62%	32.17%	32.37%	33.99%
Operating Income	-283.76M	-205.61M	-121.61M	-28.87M	25.17M	95.50M
Net Income	-307.20M	-215.56M	-186.26M	-57.44M	9.66M	66.39M
EPS	-	-	-	-	0.18	0.40
EPS Growth	-	-	-	-	211.64%	116.84%
Forward PE	278.81	278.81	278.81	278.81	228.57	32.44
Free Cash Flow	1.42M	51.65M	48.48M	100.28M	112.90M	167.72M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.7B
Avg	1.7B
Low	1.7B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	20.8%
Avg	19.9%
Low	19.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.54
Avg	0.40
Low	0.32

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	196.1%
Avg	116.8%
Low	75.4%